The third quarter of 2024 is witnessing an accelerated trend of Initial Public Offering (IPO) postponements, exemplified by biometric ring maker Oura’s recent delay, citing market “uncertainty.” This growing caution is driven by macroeconomic factors like surging bond yields and concerns over AI spending, overshadowing a year that, despite some mega-offerings, shows overall IPO activity slowing down. Companies are increasingly leveraging robust private capital markets as an alternative, allowing them to await more favorable public market valuations.
Wall Street is witnessing a significant slowdown in the Initial Public Offering (IPO) market, with postponements and withdrawals accelerating notably in the third quarter of 2024. This trend was underscored recently when biometric ring manufacturer Oura announced on Tuesday its decision to delay its anticipated IPO, citing prevalent market "uncertainty," despite also claiming robust investor demand.
While Oura faced specific scrutiny regarding its concentrated product line, market experts suggest that the broader acceleration of IPO delays is driven by systemic factors rather than isolated company issues. Matthew Kennedy, a senior strategist at IPO specialist Renaissance Capital, noted, "The fact that we've had three or four in a row – a string of postponements – I think that does tell you something about the market. You can't really point to all four of them and say it's company-specific issues."
David Paul Morris | Bloomberg | Getty Images
Data from Renaissance Capital reveals that four companies, each aiming to raise at least $50 million across various sectors, announced postponements or withdrew their IPOs entirely in the past week alone. This brings the total for the third quarter to seven, a significant jump from four in the second quarter and three in the first quarter of 2024.
Notable recent delays include Holtec Nuclear, a nuclear power component maker, which withdrew its IPO last Friday; Amaero, a materials company, postponed its offering last Wednesday; and Bamboo Insurance, which delayed its IPO on September 22. Jay Ritter, director of the IPO Initiative at the University of Florida's Warrington College of Business, echoed the sentiment, stating, "I've got a little bit of sympathy for market conditions as a rationale. The fact that three prominent companies are doing this does indicate that it's not company-specific."
A Year of Mixed Signals for IPOs
Despite the recent surge in postponements, 2024 has seen a solid, albeit mixed, performance for IPOs. Approximately $146.9 billion in proceeds has been raised across 110 deals, excluding special purpose acquisition companies, according to Renaissance Capital. This includes blockbuster offerings from SpaceX and South Korean memory giant SK Hynix in the second quarter, which significantly boosted overall proceeds.
However, the total number of IPOs this year is down 30% compared to the same period in 2023. In 2023, there were 202 IPOs, the highest count since 2021, which saw nearly 400. While total proceeds are up 394% this year, largely due to the contributions of SpaceX, SK Hynix, and Cerebras, the underlying activity shows signs of cooling.
Sector-wise, healthcare and industrials lead the charge, each accounting for 24% of IPOs year-to-date, with technology closely following at 18%. Interestingly, 59% of all 2024 offerings are currently trading at or above their IPO price, though mega-offerings like SpaceX, SK Hynix, and Cerebras are reportedly underperforming their initial valuations.
Macroeconomic Headwinds and Private Market Alternatives
The current headwinds in the IPO market are primarily macroeconomic. Rising bond yields, which hit a 19-year high, and renewed concerns about interest rate hikes have dampened investor enthusiasm. Renaissance analysts highlighted this in a recent report, stating, "IPO activity came in below expectations in the third quarter of 2024, as more concerns about AI spending, a 19-year high in bond yields and resumed rate hikes weighed on the fall pickup." The Renaissance IPO ETF (ticker: IPO) notably peaked in June 2024, coinciding with SpaceX's launch.
Experts like Gil Luria, head of technology research at DA Davidson, also point to specific investor fatigue with "narrow consumer products" when discussing Oura's challenges. He drew parallels to past issues faced by companies like Peloton, GoPro, and FitBit, suggesting investors are wary of companies with highly concentrated product lines. "I don't think it has to do with tech or tech allocation, I think it has to do with a narrow consumer product," Luria commented.
Furthermore, companies today have access to a significantly deeper and more diverse pool of private capital than in previous years. Ian Schuman, chair of capital markets and public company representation practices at Latham & Watkins, noted, "The depth of private capital and alternatives is enormous now, and much more complex and diverse. You don't necessarily, absolutely need to tap the public markets, if you're not getting the value you want." This abundance of private funding options provides companies with greater flexibility to delay public offerings until market conditions or valuations are more favorable.
– Gina Francolla contributed reporting.
